Log In
Print
BCIQ
Print
Print this Print this
 

ALX-0761

  Manage Alerts
Collapse Summary General Information
Company Ablynx N.V.
DescriptionNanobody against undisclosed target
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPreclinical
IndicationAutoimmune
Partner

Merck KGaA
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today